FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES
How to use FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Patient Information Leaflet
Flebostasin Retard 50 mg prolonged-release hard capsules
Escin
Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, consult your doctor or pharmacist.
- This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
- If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
Contents of the leaflet:
- What is Flebostasin Retard and what is it used for
- What you need to know before taking Flebostasin Retard
- How to take Flebostasin Retard
- Possible side effects
- Storage of Flebostasin Retard
- Package contents and additional information
1. What is Flebostasin Retard and what is it used for
Flebostasin Retard is a medicine that belongs to the group of capillary protectors.
Flebostasin Retard is indicated for the short-term relief (for two to three months) of edema and symptoms related to chronic venous insufficiency.
2. What you need to know before taking Flebostasin Retard
Do not take Flebostasin Retard
If you are allergic to the active substance or to any of the other components of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Flebostasin Retard.
If you have any disease, you should inform your doctor.
Children and adolescents
It should not be administered to children.
Taking Flebostasin Retard with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Since there is no adequate experience regarding the safety of Flebostasin Retard during pregnancy and breastfeeding, its use should be avoided in these situations.
Driving and using machines:
No effects have been described that affect the ability to drive and use machines.
3. How to take Flebostasin Retard
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will indicate the duration of your treatment with Flebostasin Retard.
The recommended dose is 1 capsule in the morning and 1 capsule in the evening. Take the capsules whole, without chewing, with a little liquid, and preferably before meals.
If you think the effect of Flebostasin Retard is too strong or too weak, inform your doctor or pharmacist.
If you take more Flebostasin Retard than you should
If you take more capsules than you should or if a child accidentally ingests one or more capsules, contact your doctor or go to the nearest hospital emergency department immediately and take the medicine packaging with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Flebostasin Retard
If you forget to take a dose, take the usual dose the next day. Do not take a double dose to make up for the missed doses.
If you stop taking Flebostasin Retard
Do not stop treatment without consulting your doctor, as there is a possibility that the treatment may lose its effect.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone gets them.
During treatment, you may experience stomach heaviness or mild abdominal discomfort. Skin alterations such as itching, redness, and rash may also occur, although rarely.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Flebostasin Retard
Keep out of sight and reach of children.
Store below 25°C.
Keep in the original packaging to protect from moisture.
Do not use this medicine after the expiration date stated on the packaging after the abbreviation "CAD". The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
6. Package contents and additional information
Composition of Flebostasin Retard
The active substance is escin. Each Flebostasin Retard capsule contains 50 mg of escin (corresponding to 300 mg of aesculus hippocastanum extract).
- The other components are vinylpyrrolidone-vinyl acetate copolymer, talc, dextrin, ammonio methacrylate copolymer (Type B), ammonio methacrylate copolymer (Type A), and triethyl citrate.
- Capsule components:
Gelatin, sodium lauryl sulfate, black iron oxide (E-172), red iron oxide (E-172), yellow iron oxide (E-172), titanium dioxide (E-171), indigo carmine (E-132), and quinoline yellow (E-104).
Appearance and packaging of the product
Flebostasin Retard is presented in the form of prolonged-release hard capsules. The cap of the capsule is opaque brown and the body is transparent green.
Each package contains 60 prolonged-release hard capsules.
Marketing authorization holder:
Glenwood GmbH
Pharmazeutische Erzeugnisse
Arabellastr.17
81925 Munich
Germany
Manufacturer:
SWISS CAPS GmbH
Grassingerstrasse 9
83043 Bad Aibling
Germany
Or
FARMASIERRA, S.A.
Carretera. Irún, Km. 26,200
28700 San Sebastián de los Reyes (Madrid)
Date of the last revision of this leaflet: September 2019.
Other sources of information
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULESDosage form: TABLET, 500 mgActive substance: diosmin, combinationsManufacturer: Laboratorios Servier S.L.Prescription not requiredDosage form: TABLET, 500 mgActive substance: diosmin, combinationsManufacturer: Towa Pharmaceutical S.A.Prescription not requiredDosage form: TABLET, Diosmin 450 mg / Hesperidin 50 mgActive substance: diosmin , diosmin, combinationsManufacturer: Kern Pharma S.L.Prescription not required
Online doctors for FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES
Discuss questions about FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
